Three-dimensional breast scans offers better chance to diagnose breast cancer early, at more treatable stage.
TAMPA, Fla. (June 25, 2014) – Eileen Curd does not take chances when it comes to being screened for breast cancer. Her aunt was diagnosed with the disease and all too often she hears that one of her friends was newly diagnosed.
Curd has dense breasts and has had questionable mammograms before. For the past 20 years she has been screened at Moffitt Cancer Center because she likes the convenience of having her mammogram interpreted right away by a team of specialized breast imaging radiologists. Recently, Curd decided to undergo a new mammogram that produces a 3D image of her breasts, layer by layer.
“As someone with dense breasts, I wanted to have my mammogram done at a place known for being innovative and incorporating the latest technology. Moffitt’s new 3D mammography was quick, painless and enabled my doctor to take a closer look at my breasts. I walked out the door, confident I was cancer free,” Curd said.
The 3D mammography, called breast tomosynthesis, produces a three-dimensional view of the breast tissue that helps radiologist identify and characterize individual breast structures without the confusion of overlapping tissue. The screenings are quicker, produce sharper images and are more comfortable for patients.
“We hope to expand the number of women who are able to get a comprehensive 3D breast cancer screening. Tomosythnesis can increase invasive cancer detection rates by 40 percent, compared with traditional mammograms alone. Knowing with greater certainty whether a mammogram comes back abnormal can provide peace of mind, streamline care and save lives,” said Jennifer Drukteinis, M.D., assistant member of Moffitt’s Diagnostic Imaging and Interventional Radiology Department.
The tomosynthesis screening is similar to a typical 2D mammogram for patients. Multiple, low-dose images of the breast are taken from different angles and are used to produce a series of one-millimeter thick slices that can be viewed as a reconstruction of the breast.
Breast cancer is the second leading cause of cancer death among women, behind lung cancer. One in eight women will be diagnosed with breast cancer in her lifetime. The stage at which breast cancer is detected can influence a woman’s chance of survival. If detected early, the five-year survival rate is 98 percent.
About Moffitt Cancer Center
Located in Tampa, Moffitt is one of only 41 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s excellence in research, its contributions to clinical trials, prevention and cancer control. Moffitt is the No. 1 cancer hospital in Florida and has been listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer since 1999. With more than 4,200 employees, Moffitt has an economic impact on the state of nearly $2 billion. For more information, visit MOFFITT.org, and follow the Moffitt momentum on Facebook, Twitter and YouTube.